CORPORATE ACCESS

WINTER SPRINGS, Fla., April 02, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received FDA 510(k) clearance for neonatal use of the pulse oximetry ("SpO2") and Capnography ("CO2") monitoring features of its 3880 Magnetic Resonance Imaging...

Reports fourth quarter 2018 revenue of $8.3 millionReports fourth quarter 2018 GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.16Announces 2019 full year and first quarter financial guidance WINTER SPRINGS, Fla., Feb. 06, 2019 -- IRADIMED CORPORATION...

WINTER SPRINGS, Fla., Jan. 22, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2018 fourth quarter financial results before the market opens on Wednesday, February 6th. IRADIMED management will host a conference call the...

Action being taken after CE mark expirationExpects negative impact to full-year 2019 revenue of approximately two percent WINTER SPRINGS, Fla., Jan. 22, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging...

WINTER SPRINGS, Fla., Dec. 19, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices, today announced FDA 510(k) clearance of its 3883 MRI-compatible invasive blood pressure module for...

Reports third quarter 2018 revenue of $7.6 millionReports third quarter 2018 GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.14Increases full year 2018 revenue, GAAP and non-GAAP diluted earnings guidance WINTER SPRINGS, Fla., Oct. 30, 2018 -- IRADIMED...

WINTER SPRINGS, Fla., Oct. 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 third quarter financial results before the market opens on Tuesday, October 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., Sept. 11, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical devices, today announced receipt of regulatory clearance from the Japanese Ministry of Health Labor &...

Reports second quarter 2018 revenue of $7.4 millionReports second quarter 2018 GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.14Increases full year 2018 revenue, GAAP and non-GAAP diluted earnings guidance WINTER SPRINGS, Fla., July 31, 2018 -- IRADIMED...

WINTER SPRINGS, Fla., July 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 second quarter financial results before the market opens on Tuesday, July 31st. IRADIMED management will host a conference call the same...

Reports first quarter 2018 revenue of $7.1 millionReports first quarter 2018 GAAP diluted EPS of $0.07 and non-GAAP diluted EPS of $0.10Increases full year 2018 GAAP and non-GAAP diluted EPS guidance WINTER SPRINGS, Fla., April 30, 2018 -- IRADIMED CORPORATION...

WINTER SPRINGS, Fla., April 16, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2018 first quarter financial results before the market opens on Monday, April 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., March 05, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer, will present at the 30th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled to present on Monday, March...

Reports fourth quarter 2017 revenue of $6.7 millionReports fourth quarter 2017 GAAP diluted EPS of $0.02 and non-GAAP diluted EPS of $0.10Records one-time non-cash charge of $0.5 million related to tax reform WINTER SPRINGS, Fla., Feb. 06, 2018 -- IRADIMED CORPORATION...

WINTER SPRINGS, Fla., Jan. 26, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 fourth quarter financial results before the market opens on Tuesday, February 6th. IRADIMED management will host a conference call the same...

Announces Preliminary Full Year and Fourth Quarter 2017 RevenueAnnounces Fourth Quarter 2017 Financial Results Conference Call Date WINTER SPRINGS, Fla., Jan. 22, 2018 -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic resonance...

Reports third quarter 2017 revenue of $5.7 millionReports third quarter 2017 GAAP diluted EPS of $0.02 and non-GAAP diluted EPS of $0.07Increases full year 2017 non-GAAP diluted EPS guidance WINTER SPRINGS, Fla., Oct. 30, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), a...

WINTER SPRINGS, Fla., Oct. 26, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced FDA 510(k) clearance of its 3880 Magnetic Resonance Imaging ("MRI") compatible patient vital signs monitoring system. "We are excited to announce receipt of FDA 510(k) clearance...

WINTER SPRINGS, Fla., Oct. 16, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 third quarter financial results before the market opens on Monday, October 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., Sept. 18, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the Cantor Fitzgerald Global Healthcare Conference in New York,...

Reports second quarter 2017 revenue of $5.5 millionReports second quarter 2017 GAAP diluted EPS of $0.03 and non-GAAP diluted EPS of $0.06 WINTER SPRINGS, Fla., July 28, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), a leader in the development of innovative magnetic...

WINTER SPRINGS, Fla., July 17, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 second quarter financial results before the market opens on Friday, July 28th. IRADIMED management will host a conference call the same day...

Reports first quarter 2017 revenue of $5.2 millionReports first quarter 2017 GAAP diluted EPS of $(0.02) and non-GAAP diluted EPS of $0.00Announces $8 million share repurchase program WINTER SPRINGS, Fla., April 28, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only...

WINTER SPRINGS, Fla., April 20, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2017 first quarter financial results before the market opens on Friday, April 28th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., March 30, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John McCreery has been appointed Chief Operating Officer, a new position within the Company. Mr. McCreery will have primary responsibility over the regulatory,...

WINTER SPRINGS, Fla., March 01, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Roger Susi, President and Chief Executive Officer and Chris Scott, Chief Financial Officer, will present at the 29th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi...

Reports fourth quarter 2016 revenue of $6.0 millionReports fourth quarter 2016 GAAP diluted EPS of $0.10 and non-GAAP diluted EPS of $0.11 WINTER SPRINGS, Fla., Feb. 06, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous...

WINTER SPRINGS, Fla., Jan. 25, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 fourth quarter financial results before the market opens on Monday, February 6th. IRADIMED management will host a conference call the same...

Announces Preliminary Full Year and Fourth Quarter 2016 RevenueAnnounces Fourth Quarter 2016 Financial Results Conference Call DateWINTER SPRINGS, Fla., Jan. 18, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV)...

WINTER SPRINGS, Fla., Jan. 03, 2017 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the first shipments of its MRI compatible patient vital signs monitoring system to international customers. "Shipments of the new 3880 MRI compatible patient vital signs...

WINTER SPRINGS, Fla., Dec. 19, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that it received U.S. Food and Drug Administration ("FDA") 510(k) clearance for its MRidium 3860+ magnetic resonance imaging ("MRI") compatible IV infusion pump system,...

Reports third quarter revenue of $7.7 millionReports third quarter GAAP diluted earnings per share of $0.13 and non-GAAP of $0.14 WINTER SPRINGS, Fla., Oct. 28, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), the only known provider of non-magnetic intravenous (IV)...

WINTER SPRINGS, Fla., Oct. 18, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 third quarter financial results before the market opens on Friday, October 28th. IRADIMED management will host a conference call the same...

Schedules conference call for 8:30 AM Eastern Time on Tuesday, October 4, 2016 WINTER SPRINGS, Fla., Oct. 04, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), today revised its third quarter and full year 2016 financial guidance. The Company now expects revenue for the...

Revenue grows 29.7% compared to the same quarter last yearReports second quarter 2016 GAAP diluted EPS of $0.19 and non-GAAP diluted EPS of $0.24Increases full year 2016 non-GAAP earnings guidanceSubmits patient vital signs monitor 510(k) application to FDA for review...

WINTER SPRINGS, Fla., July 15, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that the Company will release its 2016 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same day...

WINTER SPRINGS, Fla., June 28, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that Jonathan Kennedy has been appointed to the Company's Board of Directors. Mr. Kennedy, 45, currently serves as Senior Vice President and Chief Financial Officer of Natus...

WINTER SPRINGS, Fla., June 14, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) announced today that its Board of Directors voted unanimously to appoint current President and Chief Executive Officer, Roger Susi, as Chairman of the Board. The appointment was effective as of...

Provides regulatory update on the status of its MRI compatible IV infusion pump WINTER SPRINGS, Fla., June 09, 2016 -- IRADIMED CORPORATION (NASDAQ:IRMD) CURRENT NEWSIRADIMED CORPORATION has received the FDA's written response to our appeal of their determination that...

Revenue grows 28.2% compared to the same quarter last yearReports first quarter 2016 non-GAAP diluted EPS of $0.21Increases full year 2016 non-GAAP earnings guidanceAnnounces second quarter financial guidance WINTER SPRINGS, Fla., April 29, 2016 -- IRADIMED...